Snorri S. Thorgeirsson, M.D., Ph.D. - Laboratory Chief and Principal Investigator

Dr. Thorgeirsson obtained his M.D. degree in 1968 from the University of Iceland, Reykjavik. He studied biochemistry and pharmacology with Sir Colin Dollery and Prof. Donald S. Davies at the Royal Postgraduate Medical School in London, England and obtained Ph.D. from University of London in 1971. Dr. Thorgeirsson has been at the National Institutes of Health since 1972. In 1981 Dr. Thorgeirsson became Chief of the Laboratory of Experimental Carcinogenesis, National Cancer Institute. His current research interests are centered on the application of transgenic mouse models as paradigms for human diseases and stem cell biology. In 1988 he received the NIH Merit Award. He has served on editorial boards of the various scientific journals and is currently an Associate Editor for Hepatology. In addition, Dr. Thorgeirsson is a member of several professional scientific societies. He has supervised both graduate and medical school students from the United States and abroad. Dr. Thorgeirsson is also recognized both nationally and internationally by invitations to organize and chair meetings/conferences, present lectures, serve as a participant in review groups, visiting professorships, etc. He has been the U.S. Representative for the Etiology (now the Basic Sciences) Area of the US/Japan Cooperative Cancer Research Program since 1994. Dr. Thorgeirsson has published over 300 papers, including chapters in books. His current research interests focus on the use of transgenic mouse models as paradigms for human cancers, in particular liver cancer and cellular and molecular biology of hepatic stem cell compartment.